Ensuring equitable distribution of Covid vaccine around the world will see 10 of the world’s richest nations benefit by at least $153 billion over the next year, according to an economic analysis commissioned by the Bill and Melinda Gates Foundation.
The report analyses 10 major economies – including the UK, United States, France and Germany – to assess the benefits of contributing to the Act-Accelerator, a global coalition led by the World Health Organization to ensure that low and middle income countries have access to diagnostics, treatments and vaccines against Covid-19.
Dr Tedros Adhanom Ghebreyesus, director general of the WHO, says the scheme is the “global solution to ending the acute phase of the pandemic as quickly as possible”.
To read the full article, click here.